(Q50980787)

English

Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study

scientific article published on 26 November 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

0 references

neurodegeneration

1 reference

based on heuristic

inferred from title

Roberta Ghidoni

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

11

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Daniela Galimberti

12

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

13

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

16

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

object named as

Anna Paterlini

6

0 references

Fabrizio Tagliavini

object named as

Fabrizio Tagliavini

14

0 references

Chiara Fenoglio

10

object named as

Chiara Fenoglio

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Luigi Francesco Agnati

9

object named as

Luigi F Agnati

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Eleonora Pegoiani

8

object named as

Eleonora Pegoiani

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Valentina Albertini

5

object named as

Valentina Albertini

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

2

object named as

Elena Stoppani

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Michela Glionna

7

object named as

Michela Glionna

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Giacomina Rossi

3

object named as

Giacomina Rossi

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Giuliano Binetti

15

object named as

Giuliano Binetti

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

4

object named as

Elena Piccoli

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

publication date

26 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Neurodegenerative Diseases

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

9

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

121-127

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Molecular pathways of frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Progranulin Mutations are a Common Cause of FTLD in Northern Italy

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

A novel deletion in progranulin gene is associated with FTDP-17 and CBS.

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Serum biomarker for progranulin-associated frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

An algorithm for genetic testing of frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000333132

21 January 2018

Identifiers

10.1159/000333132

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22123177

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50980787&oldid=2264532594"